← SynDRA
SQ109
SynDRA canonical compound SYN0019303 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Mechanism of action | bacterial cell wall synthesis inhibitor |
| Indication | tuberculosis |
| Disease area | Infectious disease |
All known targets
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- Modulator
Cross-references
Synonyms
- Sq-109
- NSC-722041
- SQ-109
- SQ-37
- SQ-59
- Antibiotics (tuberculosis), Sequella
- Second-generation EMB, Sequella
- Second-generation ethambutol, Sequella
- N-Geranyl-N'-(2-adamantyl)ethane-1,2-diamine
- 9AU7XUV31A
- N-ADAMANTANYL-N'-GERANYL-ETHYLENEDIAMINE
- SQ109 compound
- Antibiotic SQ109
- RefChem:888881
- UNII-9AU7XUV31A
- MFCD11046358
- GTPL7997
- orb1307729
- SCHEMBL1780846
- SCHEMBL19630696
- EX-A764
- JFIBVDBTCDTBRH-REZTVBANSA-N
- GLXC-10144
- C22H38N2
- BDBM50388398
- NSC722041
- AKOS030526825
- CS-1188
- AC-31289
- DA-67735
- HY-14989
- MS-24974
- PD062226
- PD119643
- SQ109, >=98% (HPLC)
- NS00072436
- T16925
- BRD-A08772153-001-01-6
Look up SQ109 in the interactive SynDRA portal →